COMMERCIALIZATION MANAGEMENT
FROM IDEA TO EXIT
analyse the demand, clarify the solution, define the business model, develop a milestone plan with time and budget, raise capital, execute
Three decades of experience in innovation, change management and cross sectoral solution development are the backbone of our strategy.
The systemic interaction of demand and solution will define the most efficient way from A to B.
​
SERVICES AND STRATEGY
Following the nature of complex and systemic issues in processing innovation, it is the of utmost importance to clarify the most efficient way to reach traction. By understanding this important fact, we are able to support change managers and innovators.
YOU MAKE THE FIRST STEP
80% of the success is to start the process
You want to transform your idea or innovative solution into a business. You are confident about the "why" but you are struggling about the "how to" implement change, the "when to do what" and "how fast" you can go.
It all starts with moving forward and ask for support.
ANALYSE THE STATUS AND DEFINE THE GAP
Analysis is the critical starting point of strategic thinking
The analytic detection and clear circumscription of the core functionality of a solution is the entry point to reach measurable results. To define the milestones how the innovation will initiate a productivity increase on the user side is the most crucial step to a successful outcome.
SET UP ROADMAP ANDÂ MILESTONES FOR AÂ MEASURABLE SUCCESS
Valuation increase is key to fund raising
We ask the critical questions to focus the team on reducing multiple thoughts into a few feasible and efficient outcome scenario. Considering capital acquisition as an important step the process will define functions and related valuation to each milestone.
MAKE AN IMPRESSION
If you can't explain it simply, you don't understand it well enough.
Explain the need and your solution. Define the business model in a straight forward and clear way. Understand the impact on productivity and show risk aware milestones to create value for the investors. Pitch well.
SUPPORT PACKAGE
Price is what you pay, value is what you get
You know your budget and we adjust our input to your expectations.
Our
Story
Professor Dr. Christoph Schuhmacher is a medical doctor, cancer surgeon and emergency physician by training.
During his affiliation with TU-Munich, he focused on targeted research in cancer and holds patents in protein mutation-based therapy and cancer vaccination. During that time, he was member in the advisory board of various nationwide German large scale medical, nationwide practice changing research projects under the auspices of the German Ministry of Research and Education.
Leaving Munich, he served as manager at Freiburg University Heart Centre in the position of the Director of M&A.
Chris moved on as the founding operational director of ECRIN, when it was granted institutional status by the EU. ECRIN is the EU-Research Infrastructure Consortium for cross border research connecting the 27 EU-Nations and its affiliated partner countries. Here he also liaised actively with the European Forum for good Clinical Practice (EFGCP), accompanying the collaboration of EU-lawmakers, the pharmaceutical and med-tech industry, the medical associations and patient advocacy groups.
In 2016, Chris followed an opportunity as Vice President of the globally leading 5D BIM software technology provider RIB Software SE (now part of Schneider Electric CE) to serve as project leader (CEO of iTWOcity AG) for a prestigious smart city building consortium. The aim was to develop and provide technology to establish the first entirely digitally planned and build city quarter. A new personal challenge to enter into the space of digital innovation, IT-platform technologies and AI-driven business computing. During that time collaborations with McKinsey, KPMG and the Microsoft headquarter in Redmond were actively supported.
While in Hong Kong, he actively coordinated exchange programs with Hong Kong and Guangzhou based universities and supported the listing of the global enterprise IT-suite in HK SAR(CEDD). After 5 years of serving as VP and Managing director, located in Hong Kong and Guangzhou, Chris moved on as independent consultant with base in Hong Kong and Munich, now focusing entirely on supporting the complex commercialization process of innovative healthcare technologies, based on a milestone management strategy.
​
Schuhmacher Consulting today, is closely collaborating with Abridge Enterprises Company Limited, a seasoned venture capital firm and well established regional partner with successful track record in funding innovation. Abridge has the highly valuable license to conduct business in Mainland China.
Ambitious national programs of the Hong Kong SAR are actively supported by Schuhmacher Consulting.
